Antibody and CD8+ T Cell Responses against HER2/neu Required for Tumor Eradication after DNA Immunization with a Flt-3 Ligand Fusion Vaccine-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Antibody and CD8+ T Cell Responses against HER2/neu Required for Tumor Eradication after DNA Immunization with a Flt-3 Ligand Fusion Vaccine

Published:2007-10-15 Issue:20 Volume:13 Page:6195-6203
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Orlandi Francesca,Venanzi Franco M.,Concetti Antonio,Yamauchi Hanako,Tiwari Shakuntala,Norton Larry,Wolchok Jedd D.,Houghton Alan N.,Gregor Polly D.

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. La réponse immunitaire anti-tumorale dans le cancer du sein : état des lieux et perspectives thérapeutiques;Annales de Pathologie;2017-02

2. Cytomegalovirus-based cancer vaccines expressing TRP2 induce rejection of melanoma in mice;Biochemical and Biophysical Research Communications;2013-07

3. Active immunotherapy in HER2 overexpressing breast cancer: current status and future perspectives;Annals of Oncology;2013-07

4. Novel Targeted Therapies to Overcome Trastuzumab Resistance in HER2- Overexpressing Metastatic Breast Cancer;Current Drug Targets;2013-06-01

5. Whole Cell Vaccines—Past Progress and Future Strategies;Seminars in Oncology;2012-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP